Skip to main content
Top

Current Hepatology Reports

Issue 1/2019

Content (14 Articles)

Hepatitis B Hepatitis B (J Lim, Section Editor)

Prevention and Management of Hepatitis B in Healthcare Professionals

Corey R. O’Brien, Joseph K. Lim

Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Predicting Future Complications of Cirrhosis

Joel Wedd, Kavitha Nair

Endoscopy Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Non-invasive Measurement of Portal Pressure

Ahmed M. Elmahdy, Annalisa Berzigotti

Antibiotic Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Multidrug-Resistant Bacterial Infection in Patients with Cirrhosis. A Review

Lukas Otero Sanchez, Thierry Gustot

Statins Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Future Pharmacological Therapies of Portal Hypertension

Guillermo A. Ortiz, Guadalupe Garcia-Tsao

Esophageal Varices Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Cirrhosis and Autoimmune Liver Disease

Guido Stirnimann, Maryam Ebadi, Andrew L. Mason, Aldo J. Montano-Loza

Open Access Liver Transplantation Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Portal Hypertension after Liver Transplantation—Causes and Management

Lukas W. Unger, Mattias Mandorfer, Thomas Reiberger

Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Liver Involvement after a Fontan Procedure for Congenital Heart Disease

Margaret Spinosa, Karen L. Krok

Addiction Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Overcoming Alcohol Addiction in Patients with Alcohol-Related Liver Disease

Gene Y. Im

Gastrointestinal Bleeding Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

Obscure Gastrointestinal Bleeding in Cirrhosis: Work-up and Management

Sergio Zepeda-Gómez, Brendan Halloran

Hepatic Encephalopathy Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)

TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

José Ferrusquía-Acosta, Virginia Hernández-Gea

Open Access Primary Sclerosing Cholangitis Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)

Future Medical Treatment of PSC

Elisabeth Krones, Hanns-Ulrich Marschall, Peter Fickert

Open Access Fenofibrate Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)

The Role of Fibrates in Primary Biliary Cholangitis

Christophe Corpechot

Open Access Infliximab Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Kate D. Lynch, Satish Keshav, Roger W. Chapman

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine